Tag: Osteoporosis
ENDO: Osteoporosis Treatment Benefits Elderly Patients With Fragility Fracture
Benefits include lower incidence of all-cause mortality, hospitalizations
AI Can Accurately Estimate Bone Mineral Density and Classify Osteoporosis
System uses plain lumbar anteroposterior X-ray image
Air Pollution May Worsen Bone Health in Postmenopausal Women
The phospholipid C38:4 phosphatidylethanolamine may partially mediate air pollution-related bone damage
Opportunistic CT Bone Density Screening Improves Osteoporosis Screening Rate
Opportunistic CT screening could increase the number of patients screened and would result in medical cost avoidance
USPSTF Recommends Osteoporosis Screening for Women 65 Years and Older
Screening to prevent osteoporotic fractures also recommended for postmenopausal women younger than 65 years at increased risk; evidence lacking for screening men
Denosumab Increases Cardiovascular Risk in Dialysis-Dependent Patients
Denosumab has greater preventive effect on fractures, but increased risk for MACE compared with oral bisphosphonates
Risk for Emergently Treated Hypocalcemia With Denosumab Rises With CKD Stage
Risk increased with worsening CKD stage with denosumab versus bisphosphonates; highest risk seen for dialysis-dependent CKD, CKD-mineral and bone disorder
Severe Mental Illness Tied to Fragility Fractures in People 50 Years and Older
For people aged 50 years and older with severe mental illness, risk for fragility fractures is increased across all ages
USPSTF Recommends Osteoporosis Screening for Women Aged 65 Years and Older
Screening also recommended for postmenopausal women aged younger than 65 years with one or more risk factors
Osteoporosis Screening Rates Low for Asian American Medicare Beneficiaries
Among Asian American beneficiaries, rates higher for women, those with higher household income
